AZN.L - AstraZeneca PLC

LSE - LSE Delayed Price. Currency in GBp
Currency in GBp

Valuation Measures

Market Cap (intraday) 584.24B
Enterprise Value 3101.25B
Trailing P/E 33.80
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.76
Price/Book (mrq)803.55
Enterprise Value/Revenue 34.52
Enterprise Value/EBITDA 620.84

Trading Information

Stock Price History

Beta (3Y Monthly) 1.10
52-Week Change 315.74%
S&P500 52-Week Change 37.71%
52 Week High 36,634.00
52 Week Low 35,312.00
50-Day Moving Average 36,267.33
200-Day Moving Average 36,027.58

Share Statistics

Avg Vol (3 month) 32.08M
Avg Vol (10 day) 31.76M
Shares Outstanding 51.31B
Float 1.31B
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42.15
Forward Annual Dividend Yield 43.40%
Trailing Annual Dividend Rate 32.80
Trailing Annual Dividend Yield 30.04%
5 Year Average Dividend Yield 44.08
Payout Ratio 4149.73%
Dividend Date 3N/A
Ex-Dividend Date 4Feb 28, 2019
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 10.75%
Operating Margin (ttm)9.64%

Management Effectiveness

Return on Assets (ttm)2.17%
Return on Equity (ttm)17.27%

Income Statement

Revenue (ttm)22.4B
Revenue Per Share (ttm)17.68
Quarterly Revenue Growth (yoy)6.00%
Gross Profit (ttm)17.59B
Net Income Avi to Common (ttm)2.41B
Diluted EPS (ttm)190.00
Quarterly Earnings Growth (yoy)74.40%

Balance Sheet

Total Cash (mrq)4.96B
Total Cash Per Share (mrq)3.78
Total Debt (mrq)21.61B
Total Debt/Equity (mrq)179.66
Current Ratio (mrq)0.75
Book Value Per Share (mrq)7.99

Cash Flow Statement

Operating Cash Flow (ttm)2.37B
Levered Free Cash Flow (ttm)6.29B